verapamil has been researched along with Movement Disorders in 3 studies
Verapamil: A calcium channel blocker that is a class IV anti-arrhythmia agent.
verapamil : A racemate comprising equimolar amounts of dexverapamil and (S)-verapamil. An L-type calcium channel blocker of the phenylalkylamine class, it is used (particularly as the hydrochloride salt) in the treatment of hypertension, angina pectoris and cardiac arrhythmia, and as a preventive medication for migraine.
2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile : A tertiary amino compound that is 3,4-dimethoxyphenylethylamine in which the hydrogens attached to the nitrogen are replaced by a methyl group and a 4-cyano-4-(3,4-dimethoxyphenyl)-5-methylhexyl group.
Movement Disorders: Syndromes which feature DYSKINESIAS as a cardinal manifestation of the disease process. Included in this category are degenerative, hereditary, post-infectious, medication-induced, post-inflammatory, and post-traumatic conditions.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Haloperidol is a classical neuroleptic drug that is still in use and can lead to abnormal motor activity such as tardive dyskinesia (TD) following repeated administration." | 1.35 | Protective effect of L-type calcium channel blockers against haloperidol-induced orofacial dyskinesia: a behavioural, biochemical and neurochemical study. ( Bishnoi, M; Chopra, K; Kulkarni, SK, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bishnoi, M | 1 |
| Chopra, K | 1 |
| Kulkarni, SK | 1 |
| Leira, EC | 1 |
| Ajax, T | 1 |
| Adams, HP | 1 |
| Bogoliubov, VM | 1 |
| Anashkin, OD | 1 |
| Trushinskiĭ, ZK | 1 |
| Shashkov, VS | 1 |
| Shatunina, TP | 1 |
3 other studies available for verapamil and Movement Disorders
| Article | Year |
|---|---|
Protective effect of L-type calcium channel blockers against haloperidol-induced orofacial dyskinesia: a behavioural, biochemical and neurochemical study.
Topics: Animals; Antioxidants; Antipsychotic Agents; Behavior, Animal; Calcium Channel Blockers; Calcium Cha | 2008 |
Limb-shaking carotid transient ischemic attacks successfully treated with modification of the antihypertensive regimen.
Topics: Adult; Antihypertensive Agents; Brain Ischemia; Carotid Artery Diseases; Doxazosin; Humans; Male; Mo | 1997 |
[Effect of isoptin in prevention of orthostatic hypotension after hypokinesia].
Topics: Adult; Blood Pressure; Drug Evaluation; Humans; Hypotension, Orthostatic; Male; Movement Disorders; | 1978 |